Willemijn Wissink

De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum

Alma Kuechler, Marjolein H. Willemsen, Beate Albrecht et al. · Human Genetics · 2014 · 124 citations

Mendelian Disorder, Genetic Disorder, Genetics +6

Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome

Maaike Luesink, Jeroen L. A. Pennings, Willemijn Wissink et al. · Blood · 2009 · 116 citations · Full text

Expression of <i>C‐IAP1</i>, <i>C‐IAP2</i> and <i>SURVIVIN</i> discriminates different types of lymphoid malignancies

Aniek O. de Graaf, J. Han van Krieken, Evelyn Tönnissen et al. · British Journal of Haematology · 2005 · 43 citations · Full text

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +14

Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1

Jurgen A. Marteijn, Laurens T. van der Meer, Liesbeth van Emst et al. · Blood · 2007 · 33 citations

The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains

Jurgen A. Marteijn, Laurens T. van der Meer, Judith J. Smit et al. · Leukemia · 2009 · 31 citations

Hematological Malignancy, Ubiquitin Ligase Triad1, Ubc13 Interacting Domains +6